Tag: WHO News

WHO Report Unveils More Men Died Than Women During COVID-19 Pandemic

Posted on by Dennis Elnino

A new analysis from the World Health Organization (WHO) reveals that the true human cost of the COVID-19 pandemic is far higher than previously recorded. According to the World Health Statistics Report 2026, the pandemic was associated with 22.1 million excess deaths between 2020 and 2023—a figure more than triple the 7 million deaths officially reported.

The Gender Disparity in Mortality

The report highlights a significant gender gap in pandemic-related deaths. Data shows that men bore a disproportionate burden of the mortality rate, accounting for 57% of all excess deaths, while women accounted for 43%. This finding provides researchers with a deeper understanding of how the crisis affected different demographic groups across the globe.

Measuring the “True Cost”

To understand the full impact, the WHO utilized “excess mortality” as a metric. This measures the number of deaths above what is historically expected, capturing a range of factors beyond direct viral infections:

  • Direct Impact: Deaths caused specifically by COVID-19.

  • Indirect Impact: Deaths resulting from overwhelmed healthcare systems, delayed medical treatments for other conditions, economic instability, and social disruption.

The report suggests that for every one officially recorded COVID-19 death, there were approximately two additional uncounted deaths, largely due to limited testing and weak reporting systems in various regions.

Timeline of the Crisis

The global mortality surge reached its apex in 2021, during which an estimated 10.4 million people died above expected levels. This peak aligned with the rise of the Delta variant and a global shortage of critical medical resources, including hospital beds and oxygen supplies.

While excess mortality began to decline as the pandemic progressed, the effects remained lingering by 2023. Although the figure dropped to 3.3 million excess deaths that year, global mortality levels remained notably higher than pre-pandemic baselines.

A Call for Global Preparedness

The WHO emphasizes that these updated figures serve as a critical wake-up call for the international community. The report concludes that the devastating toll underscores an urgent need for:

  • Stronger health systems capable of absorbing sudden shocks.

  • Enhanced disease surveillance to ensure accurate data during crises.

  • Improved global preparedness to mitigate the impact of future health emergencies.

By revealing the hidden scale of the pandemic, the WHO aims to guide policymakers in building more resilient infrastructures to protect vulnerable populations in the years to come.

Beyond Daily Pills- WHO Backs New Long-Acting HIV Prevention Injection

Posted on by Dennis Elnino

The World Health Organization (WHO) has released groundbreaking new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention. This recommendation marks a landmark policy action poised to significantly reshape the global HIV response.

Lenacapavir, recognized as the first twice-yearly injectable PrEP product, offers a highly effective and long-acting alternative to daily oral pills and other shorter-acting prevention methods. With just two doses per year, LEN represents a transformative step forward in protecting individuals at risk of HIV, particularly those who encounter difficulties with daily medication adherence, face significant stigma, or have limited access to consistent health care.

Speaking at the 13th International AIDS Society Conference (IAS 2025) on HIV Science in Kigali, Rwanda, where the guidelines were issued, WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized the importance of this development. He stated that while an HIV vaccine remains elusive, lenacapavir stands as “the next best thing: a long-acting antiretroviral shown in trials to prevent almost all HIV infections among those at risk.”

Dr. Tedros further articulated WHO’s commitment:

“The launch of WHO’s new guidelines, alongside the FDA’s recent approval, marks a critical step forward in expanding access to this powerful tool. WHO is committed to working with countries and partners to ensure this innovation reaches communities as quickly and safely as possible.”

The issuance of these new guidelines comes at a critical juncture, as global HIV prevention efforts have shown signs of stagnation, with an alarming 1.3 million new HIV infections occurring in 2024. This impact is disproportionately felt among key and priority populations, including sex workers, men who have sex with men, transgender people, people who inject drugs, people in prisons, and children and adolescents. WHO’s recommendation on LEN signals a decisive move to expand and diversify HIV prevention strategies, providing individuals with more practical options to take control over their health with choices that better integrate into their daily lives.